Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Combination therapy with SGLT2-inhibitors and tafamidis in transthyretin cardiomyopathy
HTML
PDF
Details
Locations
Year:
2025
Type:
article
Study design:
Observational Study
Source:
Journal of Cardiology
DOI:
10.1016/j.jjcc.2025.10.004
Authors:
Kevin Chung,
Ramzi Ibrahim,
Mahmoud Abdelnabi,
Hoang Nhat,
Eiad Habib,
Mohamed Allam,
Hossam Elbenawi,
Nima Baba Ali,
Juan Farina,
Balaji Tamarappoo,
Justin Z. Lee,
Chadi Ayoub,
Kwan Lee,
D. Eric Steidley,
Dan Sorajja,
Julie Rosenthal,
Talal Hilal,
Reza Arsanjani
show all 18
Institutions:
Mayo Clinic,
Mayo Clinic Hospital,
Mayo Clinic in Arizona,
University of Arizona,
Cleveland Clinic
Language:
English
Topic:
Amyloidosis: Diagnosis, Treatment, Outcomes
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
bronze
OpenAlex ID:
W4415215954
FWCI:
0.896
Cites:
5
Cited by:
3
Related to:
10